Raphael Ognar | President & CEO
NKILT Therapeutics Inc.

Visionary and charismatic biotech executive with over 27 years of experience spanning commercial strategy, drug development, and product lifecycle management. He has held key global and regional leadership roles at top-tier pharmaceutical companies including Novartis Oncology, Celgene, and Bristol Myers Squibb, with a 22-year track record of success in Oncology and Hematology. Over the past decade, Raphaël has deepened his focus on Immuno-Oncology and Cell Therapy, culminating in the founding of NKILT Therapeutics, Inc. in 2021. Prior to this, he launched ANIM8 LLC, an executive advisory firm supporting early-stage biotech ventures and companies in real-world evidence and digital health solutions. Raphaël holds a Master’s degree and a D.E.A. in Physiology and Neurosciences from the University of Bordeaux I & II, as well as an MBA in Strategic Marketing and Enterprise Management from IAE Tours University. Beyond his commitment to advancing cancer therapies, Raphaël is an avid rock climber, vintage wine enthusiast, musician, and passionate animal rescuer who enjoys traveling the world with family and friends.